首页> 外文期刊>BMC Cancer >Genetic mutational analysis of pediatric acute lymphoblastic leukemia from a single center in China using exon sequencing
【24h】

Genetic mutational analysis of pediatric acute lymphoblastic leukemia from a single center in China using exon sequencing

机译:中国外显子测序从中国单一中心进行小儿急性淋巴细胞白血病的遗传突变分析

获取原文
           

摘要

BACKGROUND:Acute lymphoblastic leukemia (ALL), the most common childhood malignancy, is characterized by recurring structural chromosomal alterations and genetic alterations, whose detection is critical in diagnosis, risk stratification and prognostication. However, the genetic mechanisms that give rise to ALL remain poorly understood.METHODS:Using next-generation sequencing (NGS) in matched germline and tumor samples from 140 pediatric Chinese patients with ALL, we landscaped the gene mutations and estimated the mutation frequencies in this disease.RESULTS:Our results showed that the top driver oncogenes having a mutation prevalence over 5% in childhood ALL included KRAS (8.76%), NRAS (6.4%), FLT3 (5.7%) and KMT2D (5.0%). While the most frequently mutated genes were KRAS, NRAS and FLT3 in B cell ALL (B-ALL), the most common mutations were enriched in NOTCH1 (23.1%), FBXW7 (23.1%) and PHF6 (11.5%) in T cell ALL (T-ALL). These mutant genes are involved in key molecular processes, including the Ras pathway, the Notch pathway, epigenetic modification, and cell-cycle regulation. Strikingly, more than 50% of mutations occurred in the high-hyperdiploid (HeH) ALL existed in Ras pathway, especially FLT3 (20%). We also found that the epigenetic regulator gene KMT2D, which is frequently mutated in ALL, may be involved in driving leukemia transformation, as evidenced by an in vitro functional assay.CONCLUSION:Overall, this study provides further insights into the genetic basis of ALL and shows that Ras mutations are predominant in childhood ALL, especially in the high-hyperdiploid subtype in our research.
机译:背景:急性淋巴细胞白血病(全部),最常见的儿童恶性肿瘤的特征在于经常性的结构染色体改变和遗传改变,其检测对于诊断,风险分层和预后至关重要。然而,引起所有遗体理解的遗传机制。方法:使用来自140名患者的匹配种系和肿瘤样品中的下一代测序(NGS),我们揭示了基因突变并估计了这个突变频率疾病。结果:我们的结果表明,儿童时期突变患病率超过5%的顶级驾驶员诱导率包括KRA(8.76%),NRA(6.4%),FLT3(5.7%)和KMT2D(5.0%)。虽然最常突变的基因是B细胞的KRA,NRAS和FLT3均(B-全部),但最常见的突变在NOTCH1(23.1%),FBXW7(23.1%)和PHF6(11.5%)中富集(高)。这些突变基因涉及关键分子过程,包括RAS途径,凹口途径,表观遗传改性和细胞循环调节。引人注目的是,在RAS途径中存在的高超高倍数(HEH)中出现超过50%的突变,特别是FLT3(20%)。我们还发现,经常突变的表观遗传调节剂基因KMT2D可能参与驱动白血病转化,如体外功能测定所证明的那样。结论:总体而言,本研究提供了进一步的识别依赖于所有和遗传基础表明RAS突变在儿童时代占主导地位,特别是在我们研究中的高超级倍体亚型中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号